ARGX Q2 2020 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena

ARGXargenx SE

$45B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M-40.5% YoY

Gross Profit

-$138M-451.7% margin

Operating Income

-$198M-647.0% margin

Net Income

-$202M-660.6% margin

EPS (Diluted)

$-4.64

Cash Flow

Operating Cash Flow

-$133M

Free Cash Flow

-$134M

Stock-Based Comp.

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$51M	-40.5%
Gross Profit	-$138M	-$27M	-410.6%
Operating Income	-$198M	-$54M	-262.6%
Net Income	-$202M	-$45M	-346.9%

Geographic Segments

U

$22M99%

D

$120,0001%